Bios Fund I, Lp - Net Worth and Insider Trading
Bios Fund I, Lp Net Worth
The estimated net worth of Bios Fund I, Lp is at least $4 Million dollars as of 2024-12-27. Bios Fund I, Lp is the 10% Owner of Lantern Pharma Inc and owns about 1,233,802 shares of Lantern Pharma Inc (LTRN) stock worth over $4 Million. Details can be seen in Bios Fund I, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bios Fund I, Lp has not made any transactions after 2024-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bios Fund I, Lp
Bios Fund I, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bios Fund I, Lp owns 3 companies in total, including Lantern Pharma Inc (LTRN) , Cognition Therapeutics Inc (CGTX) , and Azitra Inc (AZTR) .
Click here to see the complete history of Bios Fund I, Lp’s form 4 insider trades.
Insider Ownership Summary of Bios Fund I, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2024-05-24 | 10 percent owner |
| CGTX | Cognition Therapeutics Inc | 2022-11-15 | 10 percent owner |
| AZTR | Azitra Inc | 2023-06-15 | 10 percent owner |
Bios Fund I, Lp Latest Holdings Summary
Bios Fund I, Lp currently owns a total of 1 stock. Bios Fund I, Lp owns 1,233,802 shares of Lantern Pharma Inc (LTRN) as of May 24, 2024, with a value of $4 Million.
Latest Holdings of Bios Fund I, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2024-05-24 | 1,233,802 | 3.52 | 4,342,983 |
Holding Weightings of Bios Fund I, Lp
Bios Fund I, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Bios Fund I, Lp has made a total of 6 transactions in Lantern Pharma Inc (LTRN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Lantern Pharma Inc is the sale of 30,000 shares on May 24, 2024, which brought Bios Fund I, Lp around $189,000.
Insider Trading History of Bios Fund I, Lp
- 1
Bios Fund I, Lp Trading Performance
Bios Fund I, Lp Ownership Network
Bios Fund I, Lp Owned Company Details
What does Lantern Pharma Inc do?
Who are the key executives at Lantern Pharma Inc?
Bios Fund I, Lp is the 10 percent owner of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Fletcher Aaron G.l. , and 10 percent owner Bios Capital Management, Lp .
Lantern Pharma Inc (LTRN) Insider Trades Summary
Over the past 18 months, Bios Fund I, Lp made 4 insider transaction in Lantern Pharma Inc (LTRN) with a net sale of 378,237. Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 378,237 shares made by Leslie W. Kreis ,
In summary, during the past 3 months, insiders sold 0 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 756,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 756,474 shares.
Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lantern Pharma Inc Insider Transactions
Bios Fund I, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Bios Fund I, Lp. You might contact Bios Fund I, Lp via mailing address: 1401 Foch Street, Suite 140, Fort Worth Tx 76107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
